<DOC>
	<DOCNO>NCT00089791</DOCNO>
	<brief_summary>This study evaluate effectiveness safety denosumab treat woman Postmenopausal Osteoporosis .</brief_summary>
	<brief_title>A Study Evaluate Denosumab Treatment Postmenopausal Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Denosumab</mesh_term>
	<criteria>Women 60 90 year age may eligible participate Bone mineral density ( BMD ) TScore hip spine must less 2.5 BMD TScore hip spine le 4.0 Patients severe two moderate vertebral fracture spinal xray entry</criteria>
	<gender>Female</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Postmenopausal Osteoporosis</keyword>
</DOC>